| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/16/1998 | WO1998015282A1 Immunogenic tlp composition |
| 04/16/1998 | CA2267905A1 Immunogenic tlp composition |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835107A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
| 04/15/1998 | EP0835106A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 04/15/1998 | EP0699204B1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 04/15/1998 | CN1178700A Formula for new uraemia medicine and using method |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739124 Administering an amine-containing estratriene |
| 04/14/1998 | US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0833845A1 Compounds with growth hormone releasing properties |
| 04/08/1998 | EP0833671A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833637A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | CN1178532A Tricyclic vasopressin antagonists |
| 04/08/1998 | CN1178463A Use of anti-oestrogens as male contraceptives |
| 04/08/1998 | CN1037966C Production of 4 -(5, 6, 7, 8 -tetrahydroimidazo £1.5-a| pyridine -5 -group) benzonitrile acidified hemihydrate |
| 04/07/1998 | US5736577 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| 04/07/1998 | US5736564 Endothelin receptor antagonists |
| 04/07/1998 | US5736562 Modify function of serotonin in mammals |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013033A1 Medical treatment |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2266438A1 Medical treatment |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/01/1998 | EP0832891A1 Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831864A1 Processed ginseng having enhanced pharmacological effect |
| 04/01/1998 | EP0831858A1 Intrauterine chemical necrosing method and composition |
| 04/01/1998 | EP0831829A1 Heterocyclic ring-fused pyrimidine derivatives |
| 04/01/1998 | EP0831824A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/01/1998 | EP0831822A1 Calcium channel antagonists |
| 04/01/1998 | EP0831791A1 Delivery of drugs to the lower gi tract |
| 04/01/1998 | EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | US5733902 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/31/1998 | US5733565 Male contraceptive implant |
| 03/31/1998 | US5733562 Injectable medical device and method of use |
| 03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1998011888A1 Method of treating urinary incontinence |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | CA2266070A1 Method of treating urinary incontinence |
| 03/26/1998 | CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| 03/25/1998 | EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
| 03/25/1998 | EP0628040B1 Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 03/25/1998 | CN1177356A Bicyclic benzazepine derivatives as vasopressin antagonists |
| 03/25/1998 | CN1177303A Application of lysozyme dimer |
| 03/25/1998 | CN1177297A Medicament interded to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfuctions emesa and transport sickness |
| 03/25/1998 | CN1177294A Water based topical cream contg. nitroglycerin, prepn. method therefor and use thereof |
| 03/24/1998 | USRE35752 As an aqueous solution along eith dextrose |
| 03/24/1998 | US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/24/1998 | US5731339 Administering vasodilator; phentolamine mesylate or hydrochloride |
| 03/24/1998 | US5731321 Endothelin receptor antagonists |
| 03/24/1998 | US5731293 Enzyme inhibitors |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
| 03/19/1998 | WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY |
| 03/19/1998 | WO1998011049A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 03/19/1998 | WO1998010781A1 Means for treating prostate hypertrophy and prostate cancer |
| 03/19/1998 | CA2265467A1 Ptx sensitive g proteins, the production and use thereof |
| 03/18/1998 | EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 03/18/1998 | EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy |
| 03/18/1998 | EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 03/18/1998 | EP0828712A1 Beta-adrenergic agonists |
| 03/18/1998 | EP0828500A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 03/18/1998 | CN1176600A Method for inhibiting ovarian cancer |
| 03/17/1998 | US5728738 Mixing alkali with sodium mercaptoethylsulfonate |
| 03/17/1998 | US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 03/17/1998 | US5728678 Method and composition for providing nutrition to a renal failure patient |